Evidence map›Paper›PMID 27880789›Full record

Trial reportPloS one2016

Targeting Ruminative Thinking in Adolescents at Risk for Depressive Relapse: Rumination-Focused Cognitive Behavior Therapy in a Pilot Randomized Controlled Trial with Resting State fMRI.

Rachel H Jacobs, Edward R Watkins, Amy T Peters, Claudia G Feldhaus, Alyssa Barba, Julie Carbray, Scott A Langenecker

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01905267 nacompletednot on this map

Mindfulness Intervention to Study the Neurobiology of Depression

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2013 to 2017Enrolled33ConditionsDepressionArmsRumination-Focused Cognitive Behavior Therapy
NCT03859297 narecruitingnot on this mapstarted 2019, after this paper: background citation

Developing Rumination-focused Treatment to Reduce Risk for Depression Recurrence (RDR) in Adolescence

TypeinterventionalSponsorOhio State UniversityRan2019 to 2029Enrolled183ConditionsMajor Depressive Disorder, Mood DisordersArmsRumination-Focused CBT, Relaxation-based Therapy
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rachel H JacobsDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.ORCID http://orcid.org/0000-0003-4951-2704
Edward R WatkinsMood Disorders Centre, University of Exeter, Exeter, United Kingdom.
Amy T PetersDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.
Claudia G FeldhausDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.
Alyssa BarbaDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.
Julie CarbrayDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.
Scott A LangeneckerDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States of America.
University of Illinois Chicago · USUniversity of Exeter · GB

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029879 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAZZONE, THEODORE · 2009 to 2011
$11.0M
NCRR NIH HHS UL1 RR029879
6 · The paper itself

Abstract

This pilot randomized control trial was designed to examine whether Rumination-Focused Cognitive Behavior Therapy (RFCBT) reduces rumination and residual depressive symptoms among adolescents with a history of Major Depressive Disorder (MDD) who are at risk for relapse. We also examined whether these changes in symptoms were associated with changes in functional connectivity of the posterior cingulate cortex (PCC), a key node in the default mode network (DMN). Thirty-three adolescents (ages 12-18) were randomized to eight weeks of RFCBT or an assessment only (AO) control. Twenty two adolescents successfully completed fMRI scans pre- and post-intervention. Adolescents were recruited from the clinic and community and met criteria for at least one previous episode of MDD and were currently in full or partial remission. An Independent Evaluator interviewed parent and child before and after the eight-week intervention. The left PCC (-5, -50, 36) seed was used to probe resting state functional connectivity of the DMN. Adolescents who received RFCBT demonstrated reduced rumination (F = -2.76, df = 112, p < .01, 95% CI [-4.72,-0.80]) and self-report depression across eight weeks (F = -2.58, df = 113, p < .01, 95% CI [-4.21, -0.94]). Youth who received RFCBT also demonstrated significant decreases in connectivity between the left PCC and the right inferior frontal gyrus (IFG) and bilateral inferior temporal gyri (ITG). Degree of change in connectivity was correlated with changes in self-report depression and rumination. These data suggest that rumination can be reduced over eight weeks and that this reduction is associated with parallel decreases in residual depressive symptoms and decreased functional connectivity of the left PCC with cognitive control nodes. These changes may enhance the ability of vulnerable youth to stay well during the transition to adulthood.

trial registrationClinicalTrials.gov NCT01905267.

Indexed as

Cognitive Behavioral TherapyAdolescentDepressionFeeding and Eating Disorders of ChildhoodFemaleGyrus CinguliHumansInterviews as TopicMagnetic Resonance ImagingMajor Depressive DisorderMalePilot ProjectsRecurrenceTreatment Outcome

Identifiers

PMID27880789
PMCPMC5120778
OpenAlexW2551253757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.